FOLLOWING ECIL 7
Vaccination of non-transplanted patients with haematological malignancies: Guidelines from the 2017 European Conference on Infections in Leukaemia (ECIL 7)
M MIKULSKA, S CESARO, H DE LA VALLADE, R DI BLASI, S EINARSDOTTIR, G GALLO, C RIEGER, D ENGELHARD, T LEHRNBECHER, P LJUNGMAN, C CORDONNIER
Lancet Infectious Diseases 2019, doi: 10.1016/s1473-3099(18)30601-7
Vaccination of Haematopoietic Stem Cell Transplant Recipients: Guidelines of the 2017 European Conference on Infections in Leukaemia (ECIL 7)
C CORDONNIER, S EINARSDOTTIR, S CESARO, R DI BLASI, M MIKULSKA, C RIEGER, H DE LA VALLADE, G GALLO, T LEHRNBECHER, D ENGELHARD, P LJUNGMAN
Lancet Infectious Diseases 2019, doi: 10.1016/s1473-3099(18)30600-5
Guidelines from the 2017 European Conference on Infections in Leukemia for management of HHV-6 infection in patients with hematological malignancies and after hematopoietic stem cell transplantation.
Ward KN, Hill JA, Hubacek P, de la Camara R, Crocchiolo R, Einsele H, Navarro D, Robin C, Cordonnier C, Ljungman P.
Haematologica. 2019 Aug 29. pii: haematol.2019.223073. doi: 10.3324/haematol.2019.223073
ECIL guidelines for the management of cytomegalovirus infection in patients with haematological malignancies and after stem cell transplantation
Per Ljungman, Rafael de la Camara, Christine Robin, Roberto Crocchiolo, Hermann Einsele, Joshua A Hill, Petr Hubacek, David Navarro, Catherine Cordonnier, Katherine N Ward on behalf of the 2017 European Conference on Infections in Leukaemia group
Lancet Infectious Diseases 2019, août;19(8):e260-e272. doi: 10.1016/S1473-3099(19)30107-0
Fluoroquinolone prophylaxis in haematological cancer patients with neutropenia: ECIL critical appraisal of previous guidelines.
Mikulska M, Averbuch D, Tissot F, Cordonnier C, Akova M, Calandra T, Ceppi M, Bruzzi P, Viscoli C; European Conference on Infections in Leukemia (ECIL).
J Infect. 2018 Jan;76(1):20-37. doi: 10.1016/j.jinf.2017.10.009. Epub 2017 Oct 25
ECIL guidelines on Infections associated with immunotherapeutic and molecular targeted agents in hematology and oncology
Georg Maschmeyer, Julien De Greef, Sibylle C. Mellinghoff, Annamaria Nosari, Anne Thiebaut-Bertrand, Anne Bergeron, Tomas Franquet, Nicole M. A. Blijlevens, Johan A. Maertens (on behalf of the European Conference on Infections in Leukemia (ECIL))
Received: 19 October 2018 / Revised: 31 December 2018 / Accepted: 11 January 2019
© The Author(s) 2019. This article is published with open access